|
Volumn 314, Issue 23, 2015, Pages 2499-2500
|
Engaging patients across the spectrum ofmedical product development view from the us food and drug administration
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONSUMER;
DEVICE APPROVAL;
DRUG APPROVAL;
EVIDENCE BASED MEDICINE;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE PLANNING;
HEALTH CARE SYSTEM;
HEALTH PROGRAM;
HUMAN;
MEDICAL DECISION MAKING;
MEDICAL DEVICE REGULATION;
MEDICAL SOCIETY;
OUTCOME ASSESSMENT;
PATIENT CARE;
PATIENT PARTICIPATION;
PATIENT PREFERENCE;
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
ADVISORY COMMITTEE;
DEVICES;
NEEDS ASSESSMENT;
ORGANIZATION AND MANAGEMENT;
PROCEDURES;
UNITED STATES;
BIOLOGICAL PRODUCT;
DRUG;
ADVISORY COMMITTEES;
BIOLOGICAL PRODUCTS;
EQUIPMENT AND SUPPLIES;
HUMANS;
NEEDS ASSESSMENT;
OUTCOME ASSESSMENT (HEALTH CARE);
PATIENT PARTICIPATION;
PHARMACEUTICAL PREPARATIONS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84950138272
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2015.15818 Document Type: Short Survey |
Times cited : (56)
|
References (7)
|